Studies have reported that the direct inhibition [28,53,54,55,56,57], and/or transient down-regulation, of ABCG2 [58,59,60] are two of the most common mechanisms by which multidrug-resistant cancer cells become sensitized to cytotoxic anticancer drugs. The gene discussed is ABCG2; the disease is cancer.